BioCardia, Inc. — insider transactions

11 transactions on record · BCDA · CIK 925741

Aggregates

computed from the filings below
Purchases, 12m
8
count of open-market buys
Sales, 12m
3
count of open-market sales
Buy / sell ratio, 12m
2.67
purchases per sale
Distinct insiders, 12m
2
Bought, 3m
$20.5K
Sold, 3m
$67.7K
Median disclosure lag
1.0 d
trade date to filing date
Largest single trade, 24m
$67.7K
2026-07-02
Director share, 12m
100.0%
of transactions where role is stated
Current run
8 buys
consecutive same-direction transactions
Net 3m flow
-$47.3K
purchases minus sales
Total on record
11

Transactions

11 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-07-292026-07-290Altman PeterDirector, President and CEOOpen market purchase5,000$0.78$3.9Kfiling
2026-07-202026-07-173Altman PeterDirector, President and CEOOpen market purchase500$0.83$415filing
2026-07-152026-07-150Altman PeterDirector, President and CEOOpen market purchase1,500$0.86$1.3Kfiling
2026-07-152026-07-141Altman PeterDirector, President and CEOOpen market purchase2,800$0.88$2.5Kfiling
2026-07-102026-07-091Altman PeterDirector, President and CEOOpen market purchase1,000$0.90$900filing
2026-07-102026-07-082Altman PeterDirector, President and CEOOpen market purchase5,500$0.97$5.3Kfiling
2026-07-102026-07-100Altman PeterDirector, President and CEOOpen market purchase1,000$0.94$940filing
2026-07-082026-07-080Altman PeterDirector, President and CEOOpen market purchase5,400$0.96$5.2Kfiling
2026-07-072026-07-025Altman PeterDirector, President and CEOShares withheld for tax54,606$1.24$67.7Kfiling
2026-07-072026-07-061Allen Jim L.DirectorGrant or award8,000$0.00filing
2026-07-072026-07-061Altman PeterDirector, President and CEOGrant or award57,688$0.00filing

Source: U.S. Securities and Exchange Commission, EDGAR

BioCardia, Inc. insider transactions — 11 filings on record — Tapewire